메뉴 건너뛰기




Volumn 8, Issue SUPPL. 1, 2012, Pages

Nanomedicine for treatment of diabetes in an aging population: State-of-the-art and future developments

Author keywords

Age related changes; Diabetes; Mucosa adhesive; Nanoparticulated insulin; Nasal; Oral intestinal

Indexed keywords

AGE-RELATED; AGE-RELATED CHANGES; AGING POPULATION; ANIMAL MODEL; BLOOD GLUCOSE MANAGEMENT; CRITICAL POINTS; DRUG PREPARATION; GLUCOSE MEASUREMENTS; INSULIN DELIVERY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN-DEPENDENT DIABETES; METABOLIC CHANGES; METABOLIC CONDITIONS; MUCOSA-ADHESIVE; NASAL; OLD AGE; ORAL ROUTE; ORAL/INTESTINAL; POINT OF CARE; POLYMERIC NANOPARTICLES; TARGETED NANOPARTICLE; TYPE-2 DIABETES;

EID: 84865580901     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.05.005     Document Type: Review
Times cited : (20)

References (66)
  • 1
    • 80053184864 scopus 로고    scopus 로고
    • Nanomedicine in the European Commission policy for nanotechnology
    • Gabellieri C., Frima H. Nanomedicine in the European Commission policy for nanotechnology. Nanomedicine 2011, 7:519-520.
    • (2011) Nanomedicine , vol.7 , pp. 519-520
    • Gabellieri, C.1    Frima, H.2
  • 2
    • 73749083481 scopus 로고    scopus 로고
    • Global estimates of the prevalence of diabetes for 2010 and 2030
    • Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
    • (2010) Diabetes Res Clin Pract , vol.87 , pp. 4-14
    • Shaw, J.E.1    Sicree, R.A.2    Zimmet, P.Z.3
  • 3
    • 78651276631 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
    • (2011) Diabetes Care , vol.34 , pp. 62-69
  • 4
    • 84865026205 scopus 로고    scopus 로고
    • Multiple comorbid conditions among middle-aged and elderly hemophilia patients: prevalence estimates and implications for future care
    • Khleif A.A., Rodriguez N., Brown D., Escobar M.A. Multiple comorbid conditions among middle-aged and elderly hemophilia patients: prevalence estimates and implications for future care. J Aging Res 2011, 2011:985703.
    • (2011) J Aging Res , vol.2011 , pp. 985703
    • Khleif, A.A.1    Rodriguez, N.2    Brown, D.3    Escobar, M.A.4
  • 5
    • 38149042694 scopus 로고    scopus 로고
    • An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment
    • Marchetti P., Dotta F., Lauro D., Purrello F. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008, 146:4-11.
    • (2008) Regul Pept , vol.146 , pp. 4-11
    • Marchetti, P.1    Dotta, F.2    Lauro, D.3    Purrello, F.4
  • 6
    • 45849141304 scopus 로고    scopus 로고
    • Type 2 diabetes: pathogenesis and treatment
    • Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: pathogenesis and treatment. Lancet 2008, 371:2153-2156.
    • (2008) Lancet , vol.371 , pp. 2153-2156
    • Stumvoll, M.1    Goldstein, B.J.2    van Haeften, T.W.3
  • 7
    • 78649678999 scopus 로고    scopus 로고
    • Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils
    • Misra A., Singhal N., Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 2010, 29:289S-301S.
    • (2010) J Am Coll Nutr , vol.29
    • Misra, A.1    Singhal, N.2    Khurana, L.3
  • 8
    • 0347319044 scopus 로고    scopus 로고
    • Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
    • Mangoni A.A., Jackson S.H.D. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57:6-14.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 6-14
    • Mangoni, A.A.1    Jackson, S.H.D.2
  • 9
    • 0019429337 scopus 로고
    • Insulin secretion in diabetes mellitus
    • Pfeifer M.A., Halter J.B., Porte D. Insulin secretion in diabetes mellitus. Am J Med 1981, 70:579-588.
    • (1981) Am J Med , vol.70 , pp. 579-588
    • Pfeifer, M.A.1    Halter, J.B.2    Porte, D.3
  • 10
    • 66649084335 scopus 로고    scopus 로고
    • Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice
    • Tschen S.I., Dhawan S., Gurlo T., Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009, 58:1312-1320.
    • (2009) Diabetes , vol.58 , pp. 1312-1320
    • Tschen, S.I.1    Dhawan, S.2    Gurlo, T.3    Bhushan, A.4
  • 11
    • 33845467504 scopus 로고    scopus 로고
    • Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP
    • Meier J.J., Kayed R., Lin C.Y., et al. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 2006, 291:E1317-E1324.
    • (2006) Am J Physiol Endocrinol Metab , vol.291
    • Meier, J.J.1    Kayed, R.2    Lin, C.Y.3
  • 12
    • 23744439083 scopus 로고    scopus 로고
    • Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
    • Gunton J.E., Kulkarni R.N., Yim S., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.
    • (2005) Cell , vol.122 , pp. 337-349
    • Gunton, J.E.1    Kulkarni, R.N.2    Yim, S.3
  • 13
    • 20044390365 scopus 로고    scopus 로고
    • Functional and molecular defects of pancreatic islets in human type 2 diabetes
    • Del Guerra S., Lupi R., Marselli L., et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005, 54:727-735.
    • (2005) Diabetes , vol.54 , pp. 727-735
    • Del Guerra, S.1    Lupi, R.2    Marselli, L.3
  • 14
    • 33644772589 scopus 로고    scopus 로고
    • Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients
    • Ostenson C.G., Gaisano H., Sheu L., Tibell A., Bartfai T. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006, 55:435-440.
    • (2006) Diabetes , vol.55 , pp. 435-440
    • Ostenson, C.G.1    Gaisano, H.2    Sheu, L.3    Tibell, A.4    Bartfai, T.5
  • 15
    • 38849135820 scopus 로고    scopus 로고
    • The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
    • Brun T., Hu He K.H., Lupi R., et al. The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum Mol Genet 2008, 17:478-489.
    • (2008) Hum Mol Genet , vol.17 , pp. 478-489
    • Brun, T.1    Hu He, K.H.2    Lupi, R.3
  • 16
    • 34547702501 scopus 로고    scopus 로고
    • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
    • Lyssenko V., Lupi R., Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163.
    • (2007) J Clin Invest , vol.117 , pp. 2155-2163
    • Lyssenko, V.1    Lupi, R.2    Marchetti, P.3
  • 17
    • 8744272467 scopus 로고    scopus 로고
    • Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin
    • Marchetti P., Del Guerra S., Marselli L., et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004, 89:5535-5541.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5535-5541
    • Marchetti, P.1    Del Guerra, S.2    Marselli, L.3
  • 18
    • 67249096093 scopus 로고    scopus 로고
    • Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
    • Shu L., Matveyenko A.V., Kerr-Conte J., Cho J.H., McIntosh C.H., Maedler K. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009, 18:2299-2388.
    • (2009) Hum Mol Genet , vol.18 , pp. 2299-2388
    • Shu, L.1    Matveyenko, A.V.2    Kerr-Conte, J.3    Cho, J.H.4    McIntosh, C.H.5    Maedler, K.6
  • 19
    • 71549166982 scopus 로고    scopus 로고
    • Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals
    • Nyblom H.K., Bugliani M., Fung E., et al. Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals. J Proteome Res 2009, 8:5650-5656.
    • (2009) J Proteome Res , vol.8 , pp. 5650-5656
    • Nyblom, H.K.1    Bugliani, M.2    Fung, E.3
  • 20
    • 33847012626 scopus 로고    scopus 로고
    • Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets
    • Ritzel R.A., Meier J.J., Lin C.Y., Veldhuis J.D., Butler P.C. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 2007, 56:65-71.
    • (2007) Diabetes , vol.56 , pp. 65-71
    • Ritzel, R.A.1    Meier, J.J.2    Lin, C.Y.3    Veldhuis, J.D.4    Butler, P.C.5
  • 22
    • 30044434823 scopus 로고    scopus 로고
    • MicroRNAs: 'ribo-regulators' of glucose homeostasis
    • Gauthier B.R., Wollheim C.B. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 2006, 12:36-38.
    • (2006) Nat Med , vol.12 , pp. 36-38
    • Gauthier, B.R.1    Wollheim, C.B.2
  • 23
    • 33644982043 scopus 로고    scopus 로고
    • MicroRNAs as therapeutic targets
    • Czech M.P. MicroRNAs as therapeutic targets. The New Eng J Med 2006, 354:1194-1195.
    • (2006) The New Eng J Med , vol.354 , pp. 1194-1195
    • Czech, M.P.1
  • 25
    • 77953439038 scopus 로고    scopus 로고
    • DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting type 2 diabetes
    • Hayashi Y., Kajimoto K., Iida S., et al. DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting type 2 diabetes. Biol. Pharm. Bull. 2010, 33:1033-1042.
    • (2010) Biol. Pharm. Bull. , vol.33 , pp. 1033-1042
    • Hayashi, Y.1    Kajimoto, K.2    Iida, S.3
  • 26
    • 80052433997 scopus 로고    scopus 로고
    • Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
    • Ohtsubo K., Chen M.Z., Olefsky J.M., Marth J.D. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 2011, 17:1067-1076.
    • (2011) Nat Med , vol.17 , pp. 1067-1076
    • Ohtsubo, K.1    Chen, M.Z.2    Olefsky, J.M.3    Marth, J.D.4
  • 27
  • 28
    • 78649817896 scopus 로고    scopus 로고
    • A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles
    • Tran H.N.A., Sousa F., Moda F., et al. A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. Nanoscale 2010, 2:2724-2732.
    • (2010) Nanoscale , vol.2 , pp. 2724-2732
    • Tran, H.N.A.1    Sousa, F.2    Moda, F.3
  • 30
    • 36248965689 scopus 로고    scopus 로고
    • Current challenges in non-invasive insulin delivery systems: a comparative review
    • Khafagy el-S, Morishita M., Onuki Y., Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007, 59:1521-1546.
    • (2007) Adv Drug Deliv Rev , vol.59 , pp. 1521-1546
    • Khafagy, E.-S.1    Morishita, M.2    Onuki, Y.3    Takayama, K.4
  • 31
    • 73549111762 scopus 로고    scopus 로고
    • Challenges and advances in nanoparticle-based oral insulin delivery
    • Ramesan R.M., Sharma C.P. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev Med Devices 2009, 6:665-676.
    • (2009) Expert Rev Med Devices , vol.6 , pp. 665-676
    • Ramesan, R.M.1    Sharma, C.P.2
  • 32
    • 77957285711 scopus 로고    scopus 로고
    • Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats
    • Sharma G., Wilson K., van der Walle C.F., Sattar N., Petrie J.R., Ravi Kumar M.N. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm 2010, 76:159-169.
    • (2010) Eur J Pharm Biopharm , vol.76 , pp. 159-169
    • Sharma, G.1    Wilson, K.2    van der Walle, C.F.3    Sattar, N.4    Petrie, J.R.5    Ravi Kumar, M.N.6
  • 33
    • 79954628593 scopus 로고    scopus 로고
    • Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery
    • Makhlof A., Tozuka Y., Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011, 42:445-451.
    • (2011) Eur J Pharm Sci , vol.42 , pp. 445-451
    • Makhlof, A.1    Tozuka, Y.2    Takeuchi, H.3
  • 34
    • 78650710879 scopus 로고    scopus 로고
    • Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin
    • Zhang Y., Wei W., Lv P., Wang L., Ma G. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm 2011, 77:11-19.
    • (2011) Eur J Pharm Biopharm , vol.77 , pp. 11-19
    • Zhang, Y.1    Wei, W.2    Lv, P.3    Wang, L.4    Ma, G.5
  • 35
    • 80052599281 scopus 로고    scopus 로고
    • Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin
    • Elsayed A., Al-Remawi M., Qinna N., Farouk A., Al-Souod K.A., Badwan A.A. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. AAPS PharmSciTech 2011, 12:958-964.
    • (2011) AAPS PharmSciTech , vol.12 , pp. 958-964
    • Elsayed, A.1    Al-Remawi, M.2    Qinna, N.3    Farouk, A.4    Al-Souod, K.A.5    Badwan, A.A.6
  • 36
    • 34250835820 scopus 로고    scopus 로고
    • Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin
    • Bhumkar D.R., Joshi H.M., Sastry M., Pokharkar V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 2007, 24:1415-1426.
    • (2007) Pharm Res , vol.24 , pp. 1415-1426
    • Bhumkar, D.R.1    Joshi, H.M.2    Sastry, M.3    Pokharkar, V.B.4
  • 37
    • 79954420700 scopus 로고    scopus 로고
    • Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents
    • Chaudhury A., Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011, 12:10-20.
    • (2011) AAPS PharmSciTech , vol.12 , pp. 10-20
    • Chaudhury, A.1    Das, S.2
  • 38
    • 60849101842 scopus 로고    scopus 로고
    • Chitosan and its use in design of insulin delivery system
    • Wong T.W. Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul 2009, 3:8-25.
    • (2009) Recent Pat Drug Deliv Formul , vol.3 , pp. 8-25
    • Wong, T.W.1
  • 39
    • 80054061227 scopus 로고    scopus 로고
    • A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
    • Chen M.-C., Sonaje K., Chen K.-J., Sung H.-W. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 2011, 10.1016/j.biomaterials.2011.08.087.
    • (2011) Biomaterials
    • Chen, M.-C.1    Sonaje, K.2    Chen, K.-J.3    Sung, H.-W.4
  • 40
    • 60149111908 scopus 로고    scopus 로고
    • Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
    • Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009, 61:158-171.
    • (2009) Adv Drug Deliv Rev , vol.61 , pp. 158-171
    • Lai, S.K.1    Wang, Y.Y.2    Hanes, J.3
  • 41
    • 42349105761 scopus 로고    scopus 로고
    • Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
    • Wells J.M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6:349-362.
    • (2008) Nat Rev Microbiol , vol.6 , pp. 349-362
    • Wells, J.M.1    Mercenier, A.2
  • 42
    • 33644836828 scopus 로고    scopus 로고
    • A case of anaphylaxis caused by the health food chitosan
    • Kato Y., Yagami A., Matsunaga K. A case of anaphylaxis caused by the health food chitosan. Arerugi 2005, 54(12):1427-1429.
    • (2005) Arerugi , vol.54 , Issue.12 , pp. 1427-1429
    • Kato, Y.1    Yagami, A.2    Matsunaga, K.3
  • 43
    • 58149091806 scopus 로고    scopus 로고
    • The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity
    • Vaarala O., Atkinson M.A., Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57:2555-2562.
    • (2008) Diabetes , vol.57 , pp. 2555-2562
    • Vaarala, O.1    Atkinson, M.A.2    Neu, J.3
  • 44
    • 0023411755 scopus 로고
    • Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use
    • Brogden R.N., Heel R.C. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs 1987, 34:350-371.
    • (1987) Drugs , vol.34 , pp. 350-371
    • Brogden, R.N.1    Heel, R.C.2
  • 45
    • 0027640323 scopus 로고
    • Gastric mucosal blood flow and blood viscosity in patients with diabetes
    • 511
    • Zhu L. Gastric mucosal blood flow and blood viscosity in patients with diabetes. Zhonghua Yi Xue Za Zhi 1993, 73:476-478. 511.
    • (1993) Zhonghua Yi Xue Za Zhi , vol.73 , pp. 476-478
    • Zhu, L.1
  • 47
    • 0029040056 scopus 로고
    • The thickness of the mucus layer in different segments of the rats intestine
    • Szentkuti L., Lorenz K. The thickness of the mucus layer in different segments of the rats intestine. Histochem J 1995, 27:466-472.
    • (1995) Histochem J , vol.27 , pp. 466-472
    • Szentkuti, L.1    Lorenz, K.2
  • 49
    • 77957264181 scopus 로고    scopus 로고
    • Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles
    • Woitiski C.B., Neufeld R.J., Veiga F., Carvalho R.A., Figueiredo I.V. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci 2010, 41:556-563.
    • (2010) Eur J Pharm Sci , vol.41 , pp. 556-563
    • Woitiski, C.B.1    Neufeld, R.J.2    Veiga, F.3    Carvalho, R.A.4    Figueiredo, I.V.5
  • 50
    • 74049130927 scopus 로고    scopus 로고
    • Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes
    • Damgé C., Socha M., Ubrich N., Maincent P. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. J Pharm Sci 2010, 99:879-889.
    • (2010) J Pharm Sci , vol.99 , pp. 879-889
    • Damgé, C.1    Socha, M.2    Ubrich, N.3    Maincent, P.4
  • 51
    • 84873066597 scopus 로고    scopus 로고
    • http://www.businesswire.com/portal/site/home/email/alert/%3FndmViewId=news_view%26newsLang=en%26newsId=20080409005647.
  • 52
    • 52749089075 scopus 로고    scopus 로고
    • Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes
    • Liu M.C., Riese R.J., Van Gundy K., Norwood P., Sullivan B.E., Schwartz P.F., et al. Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. Eur Respir J 2008, 32:180-188.
    • (2008) Eur Respir J , vol.32 , pp. 180-188
    • Liu, M.C.1    Riese, R.J.2    Van Gundy, K.3    Norwood, P.4    Sullivan, B.E.5    Schwartz, P.F.6
  • 53
    • 79952317008 scopus 로고    scopus 로고
    • The influence of pulmonary surfactant on nanoparticulate drug delivery systems
    • Schleh C., Rothen-Rutishauser B., Kreyling W.G. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm 2011, 77:350-352.
    • (2011) Eur J Pharm Biopharm , vol.77 , pp. 350-352
    • Schleh, C.1    Rothen-Rutishauser, B.2    Kreyling, W.G.3
  • 54
    • 0035997333 scopus 로고    scopus 로고
    • Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
    • Dyer A.M., Hinchcliffe M., Watts P., et al. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res 2002, 19:998-1008.
    • (2002) Pharm Res , vol.19 , pp. 998-1008
    • Dyer, A.M.1    Hinchcliffe, M.2    Watts, P.3
  • 55
    • 26844496437 scopus 로고    scopus 로고
    • Long-term clearance from small airways decreases with age
    • Svartengren M., Falk R., Philipson K. Long-term clearance from small airways decreases with age. Eur Respir J 2005, 26:609-615.
    • (2005) Eur Respir J , vol.26 , pp. 609-615
    • Svartengren, M.1    Falk, R.2    Philipson, K.3
  • 56
    • 0033035039 scopus 로고    scopus 로고
    • Physiological changes in respiratory function associated with ageing
    • Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999, 13:197-205.
    • (1999) Eur Respir J , vol.13 , pp. 197-205
    • Janssens, J.P.1    Pache, J.C.2    Nicod, L.P.3
  • 57
    • 17144404203 scopus 로고    scopus 로고
    • Animal models of diabetes mellitus
    • Rees D.A., Alcolado J.C. Animal models of diabetes mellitus. Diabet Med 2005, 22:359-370.
    • (2005) Diabet Med , vol.22 , pp. 359-370
    • Rees, D.A.1    Alcolado, J.C.2
  • 58
    • 77953770453 scopus 로고    scopus 로고
    • The future of mucosal immunology: studying an integrated system-wide organ
    • Gill N., Wlodarska M., Finlay B.B. The future of mucosal immunology: studying an integrated system-wide organ. Nat Immunol 2010, 11:558-560.
    • (2010) Nat Immunol , vol.11 , pp. 558-560
    • Gill, N.1    Wlodarska, M.2    Finlay, B.B.3
  • 59
    • 60149088354 scopus 로고    scopus 로고
    • Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines
    • Mrsny R.J. Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines. Drug Deliv Rev 2009, 61:172-192.
    • (2009) Drug Deliv Rev , vol.61 , pp. 172-192
    • Mrsny, R.J.1
  • 60
    • 34547638958 scopus 로고    scopus 로고
    • High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes
    • Huang C.J., Lin C.Y., Haataja L., et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007, 56:2016-2027.
    • (2007) Diabetes , vol.56 , pp. 2016-2027
    • Huang, C.J.1    Lin, C.Y.2    Haataja, L.3
  • 61
    • 79954580272 scopus 로고    scopus 로고
    • Current prospects for RNA interference-based therapies
    • Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011, 12:329-340.
    • (2011) Nat Rev Genet , vol.12 , pp. 329-340
    • Davidson, B.L.1    McCray, P.B.2
  • 62
    • 33847018785 scopus 로고    scopus 로고
    • Oral insulin-mimetic compounds that act independently of insulin
    • García-Vicente S., Yraola F., Marti L., et al. Oral insulin-mimetic compounds that act independently of insulin. Diabetes 2007, 56:486-493.
    • (2007) Diabetes , vol.56 , pp. 486-493
    • García-Vicente, S.1    Yraola, F.2    Marti, L.3
  • 63
    • 79954609233 scopus 로고    scopus 로고
    • Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release
    • Wu Z., Zhang S., Zhang X., Shu S., Chu T., Yu D. Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release. J Pharm Sci 2011, 100:2278-2286.
    • (2011) J Pharm Sci , vol.100 , pp. 2278-2286
    • Wu, Z.1    Zhang, S.2    Zhang, X.3    Shu, S.4    Chu, T.5    Yu, D.6
  • 64
    • 78650146293 scopus 로고    scopus 로고
    • Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH
    • Wu W., Mitra N., Yan E.C., Zhou S. Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH. ACS Nano 2010, 4:4831-4839.
    • (2010) ACS Nano , vol.4 , pp. 4831-4839
    • Wu, W.1    Mitra, N.2    Yan, E.C.3    Zhou, S.4
  • 65
    • 79952926478 scopus 로고    scopus 로고
    • Water-in-oil microemulsions for effective transdermal delivery of proteins
    • Russell-Jones G., Himes R. Water-in-oil microemulsions for effective transdermal delivery of proteins. Expert Opin Drug Deliv 2011, 8:537-546.
    • (2011) Expert Opin Drug Deliv , vol.8 , pp. 537-546
    • Russell-Jones, G.1    Himes, R.2
  • 66
    • 77956224955 scopus 로고    scopus 로고
    • Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds
    • Hrynyk M., Martins-Green M., Barron A.E., Neufeld R.J. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010, 398:146-154.
    • (2010) Int J Pharm , vol.398 , pp. 146-154
    • Hrynyk, M.1    Martins-Green, M.2    Barron, A.E.3    Neufeld, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.